Rochelle B. Lazarus's most recent trade in Blackstone Inc was a trade of 1,736 Common Stock done . Disclosure was reported to the exchange on July 9, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Blackstone Inc | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 1,736 | 56,412 (0%) | 0% | 0 | Common Stock | |
Organon & Co. | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,638 | 36,454 | - | - | Phantom Stock | |
Blackstone Inc | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2023 | 2,283 | 54,676 (0%) | 0% | 0 | Common Stock | |
Organon & Co. | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 10,086 | 25,285 | - | - | Phantom Stock | |
Blackstone Inc | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2022 | 2,181 | 52,393 (0%) | 0% | 0 | Common Stock | |
Organon & Co. | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 5,640 | 14,638 | - | - | Phantom Stock | |
Blackstone Inc | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2021 | 2,123 | 50,212 (0%) | 0% | 0 | Common Stock | |
Organon & Co. | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 8,772 | 8,772 | - | - | Phantom Stock | |
Blackstone Inc | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 3,933 | 48,089 (0%) | 0% | 0 | Class A Common Stock | |
Merck & Co Inc | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 389 | 87,596 | - | - | Phantom Stock |